CSF2 and gastric cancer: The result of this study revealed a new modulating mechanism of B7-H4 expression on neutrophils that can activate tumors in GC, proposing that efficient suppression of these new GM-CSF-B7-H4 pathways could be an appropriate strategy in GC therapy [124].